Mabs Healthcare & Consulting Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 11 Year, 10 Months
- Last Filing with ROC 31 Mar 2020
- Revenue Growth -57.54%
- Profit Growth 184.50%
- Ebitda -309.43%
- Net Worth 15.37%
- Total Assets -1.27%
About Mabs Healthcare & Consulting
Mabs Healthcare & Consulting Private Limited (MHCPL) is a Private Limited Indian Non-Government Company incorporated in India on 02 April 2013 and has a history of 11 years and ten months. Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Sunitha Binu and Binu Cheriyan serve as directors at the Company.
Company Details
-
Location
Bangaluru, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U73100KA2013PTC068411
-
Company No.
068411
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
02 Apr 2013
-
Date of AGM
31 Dec 2020
-
Date of Balance Sheet
31 Mar 2020
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Mabs Healthcare & Consulting?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sunitha Binu
|
Director | 02-Apr-2013 | Current |
|
Binu Cheriyan
|
Director | 10-Mar-2016 | Current |
Financial Performance of Mabs Healthcare & Consulting.
Mabs Healthcare & Consulting Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 57.54% decrease. The company also saw a substantial improvement in profitability, with a 184.5% increase in profit. The company's net worth Soared by an impressive increase of 15.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mabs Healthcare & Consulting?
In 2018, Mabs Healthcare & Consulting had a promoter holding of 50.00% and a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Luxmed Healthcare And Consulting Private LimitedSunitha Binu and Binu Cheriyan are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Mabs Healthcare & Consulting?
Unlock and access historical data on people associated with Mabs Healthcare & Consulting, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mabs Healthcare & Consulting, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mabs Healthcare & Consulting's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
